These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 19694470

  • 1. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells.
    Antoon JW, Liu J, Gestaut MM, Burow ME, Beckman BS, Foroozesh M.
    J Med Chem; 2009 Sep 24; 52(18):5748-52. PubMed ID: 19694470
    [Abstract] [Full Text] [Related]

  • 2. Novel D: -erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics.
    Antoon JW, Liu J, Ponnapakkam AP, Gestaut MM, Foroozesh M, Beckman BS.
    Cancer Chemother Pharmacol; 2010 May 24; 65(6):1191-5. PubMed ID: 20155475
    [Abstract] [Full Text] [Related]

  • 3. Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer.
    Antoon JW, Beckman BS.
    Bioorg Med Chem Lett; 2012 Apr 01; 22(7):2624-8. PubMed ID: 22366655
    [Abstract] [Full Text] [Related]

  • 4. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells.
    Crawford KW, Bittman R, Chun J, Byun HS, Bowen WD.
    Cell Mol Biol (Noisy-le-grand); 2003 Nov 01; 49(7):1017-23. PubMed ID: 14682383
    [Abstract] [Full Text] [Related]

  • 5. Novel anti-viability ceramide analogs: design, synthesis, and structure-activity relationship studies of substituted (S)-2-(benzylideneamino)-3-hydroxy-N-tetradecylpropanamides.
    Liu J, Antoon JW, Ponnapakkam A, Beckman BS, Foroozesh M.
    Bioorg Med Chem; 2010 Jul 15; 18(14):5316-22. PubMed ID: 20639111
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
    Chintalapati M, Truax R, Stout R, Portier R, Losso JN.
    J Agric Food Chem; 2009 Jun 24; 57(12):5201-10. PubMed ID: 19476359
    [Abstract] [Full Text] [Related]

  • 8. Anticancer activity of a ceramide analog containing a disulfide linkage.
    Bittman R, Li Z, Samadder P, Arthur G.
    Cancer Lett; 2007 Jun 18; 251(1):53-8. PubMed ID: 17141948
    [Abstract] [Full Text] [Related]

  • 9. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
    Furlong SJ, Mader JS, Hoskin DW.
    Oncol Rep; 2006 May 18; 15(5):1385-90. PubMed ID: 16596215
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological activity of novel shikonin analogues.
    Wang W, Dai M, Zhu C, Zhang J, Lin L, Ding J, Duan W.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):735-7. PubMed ID: 19111464
    [Abstract] [Full Text] [Related]

  • 11. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
    Awad AB, Barta SL, Fink CS, Bradford PG.
    Mol Nutr Food Res; 2008 Apr 01; 52(4):419-26. PubMed ID: 18338406
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synthesis of a novel ceramide analogue via Tebbe methylenation and evaluation of its antiproliferative activity.
    Lu X, Arthur G, Bittman R.
    Org Lett; 2005 Apr 14; 7(8):1645-8. PubMed ID: 15816773
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Design, synthesis, and preliminary biological evaluation of a novel triazole analogue of ceramide.
    Kim S, Cho M, Lee T, Lee S, Min HY, Lee SK.
    Bioorg Med Chem Lett; 2007 Aug 15; 17(16):4584-7. PubMed ID: 17561396
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
    Labbozzetta M, Notarbartolo M, Poma P, Maurici A, Inguglia L, Marchetti P, Rizzi M, Baruchello R, Simoni D, D'Alessandro N.
    Ann N Y Acad Sci; 2009 Feb 15; 1155():278-83. PubMed ID: 19250217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.